Columbia Sportswear Reports Q4 Beat Amidst Weak Q1 2026 Outlook and Tariff Headwinds
summarizeSummary
Columbia Sportswear exceeded Q4 2025 expectations but issued a weak Q1 2026 outlook with significant EPS decline, while providing modest full-year 2026 guidance amidst tariff pressures.
check_boxKey Events
-
Q4 2025 Results Exceed Guidance
Net sales decreased 2% to $1.07 billion, and diluted EPS was $1.73, both surpassing the company's internal guidance for the quarter.
-
Full Year 2025 Performance
Net sales increased 1% to $3.40 billion, but diluted EPS fell to $3.24 from $3.82 in 2024, impacted by $29 million in impairment charges related to prAna and Mountain Hardwear.
-
Weak Q1 2026 Financial Outlook
The company forecasts a net sales decline of 2.5-4.0% and a significant drop in diluted EPS to $0.29-$0.37, down from $0.75 in Q1 2025, primarily due to lower U.S. wholesale and DTC sales and tariff impacts.
-
Modest Full Year 2026 Guidance
Projects net sales growth of 1.0-3.0% ($3.43B-$3.50B) and diluted EPS of $3.20-$3.65, indicating potential for flat to modest growth compared to 2025.
auto_awesomeAnalysis
Columbia Sportswear reported fourth quarter 2025 financial results that exceeded its own guidance, driven by better-than-expected U.S. wholesale orders. However, the company provided a significantly weaker outlook for the first quarter of 2026, projecting a substantial decline in diluted earnings per share compared to the prior year. The full year 2026 guidance indicates modest net sales growth and a diluted EPS range that could be flat to slightly positive, reflecting ongoing challenges from incremental U.S. tariffs which are expected to contract gross margins. Investors should note the near-term headwinds indicated by the Q1 2026 forecast, despite the Q4 2025 beat, as the company continues to execute its 'ACCELERATE Growth Strategy' and 'Profit Improvement Plan' to drive long-term efficiency and growth.
At the time of this filing, COLM was trading at $61.42 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $47.47 to $92.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.